Neuravi is dedicated to improving clinical outcomes for stroke patients. The company’s stroke therapy platform, the EmboTrap®II Revascularization Device, is CE marked and commercially available in Europe. The device has been available for investigational use only in the United States. Through its investment in the Neuravi Thromboembolic Initiative (NTI), Neuravi supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics, in order to improve patient outcomes in stroke.
In April 2017, Codman Neuro announced the acquisition of Neuravi, which is now part of the Johnson and Johnson family of medical device companies. Neuravi was founded in 2009 and is headquartered in Galway, Ireland.
Company Details
- Employees
- 3
- Founded
- -
- Phone
- 353 9 139 4114
- in****@****avi.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- neuravi.com
- Keywords
- Oranmore.
Neuravi Questions
Neuravi's helpline number is 353 9 139 4114
Neuravi's website is neuravi.com
Neuravi's LinkedIn profile is https://ie.linkedin.com/company/neuravi
Neuravi has
3 employees.
View email and phone details for 3
employees at Neuravi.
Neuravi's industry is
Medical Equipment Manufacturing
Neuravi's top competitors are
Aerogen,
Apica Cardiovascular Ltd.,
Medtronic,
Aurigen Medical,
Vivasure Medical Ltd.,
Neurava Inc.,
Innovo,
Veryan Medical,
Bluedrop Medical,
Loci Orthopaedics.
Neuravi's support email address is info@neuravi.com
Neuravi's categories are Medical Equipment Manufacturing
Neuravi's founding year is 2009
